Comparative drug survival and effectiveness of interleukin-17 inhibitors versus selective interleukin-23 inhibitors following discontinuation of ustekinumab in plaque psoriasis
A retrospective cohort study.
Sotiriou E, Chaitidis N, Tsentemeidou A, Varvara ST, Papadimitriou I, Chiotis S, Chatzigeorgiou I, Arabatzis M, Kiritsi D, Vakirlis E
Journal of the American Academy of DermatologyIn the feed 11 Sep 2026, published online 11 Sep 2026, issue 2026 Sep 11, added to PubMed 11 Sep 2026
Topics: Psoriasis
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42726047 · DOI 10.1016/j.jaad.2026.08.052